Role of extracellular matrix in pancreatic diseases

Digestion

Volumn 59, Issue 6, 1998, Pages 625-637

  Gress, T M ^a   Menke, A ^a   Bachem, M ^a   Muller Pillasch F ^a   Ellenrieder, V ^a   Weidenbach, H ^a   Wagner, M ^a   Adler, G ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Desmoplasia; Extracellular matrix; Fibrosis; Pancreatic cancer; Pancreatitis

Indexed keywords

CERULETIDE; DIBUTYLTIN DICHLORIDE; GROWTH FACTOR; PROTEINASE; PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CYSTIC FIBROSIS; EXTRACELLULAR MATRIX; PANCREAS CANCER; PANCREAS DISEASE; PANCREATITIS; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; METALLOENDOPEPTIDASES; MICE; MICE, TRANSGENIC; PANCREATIC DISEASES; RATS; RNA;

EID: 0031794595     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007567     Document Type: Review

References (72)

1. Piez KA, Reddi AH: Extracellular Matrix Biochemistry. New York, Elsevier, 1984.
2. Hay RD: Cell Biology of Extracellular Matrix, ed 2. New York, Plenum Press, 1991.
3. Royce PM, Steinmann B: Connective Tissue and Its Heritable Disorders: Molecular, Genetic and Medical Aspects. New York, Wiley-Liss, 1993.
4. Labat-Robert J, Bihari-Varga M, Robert L: Extracellular matrix. FEBS Lett 1990;268:386-393.
5. Cohen IK, Diegelmann RF, Lindblad WJ: Wound Healing: Biochemical and Clinical Aspects. Philadelphia, Saunders, 1992.
6. Zern MA, Reid LM: Extracellular Matrix: Chemistry, Biology and Pathobiology with Emphasis on the Liver. New York, Marcel Decker, 1993.
7. Hay ED: Cell and extracellular matrix: Their organization and mutual dependence. Mod Cell Biol 1983;2:509-548.
8. Trelstad RL: The Role of the Extracellular Matrix in Development. New York, Liss, 1984.
9. Juliano RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 1993;120: 577-585.
10. Ruoslahti E: Integrins. J Clin Invest 1991;87: 1-5.
11. Hynes RO: Integrins: A family of cell surface receptors. Cell 1987;48:549-552.
12. Rapraeger AC: The coordinated regulation of heparan sulfate, syndecans and cell behavior. Curr Opin Cell Biol 1993;5:844-853.
13. Kennedy RH, Bockman DE, Uscanga L, Choux R, Grimaud JA, Sarles H: Pancreatic extracellular matrix alterations in chronic pancreatitis. Pancreas 1987;2:61-72.
14. Gress TM, Müller-Pillasch F, Lerch MM, Friess H, Büchler M, Beger HG, Adler G: Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis. Z Gastroenterol 1994;32:221-225.
15. Gress TM, Müller-Pillasch F, Lerch MM, Friess H, Büchler M, Adler G: Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer 1995;62:407-413.
16. Klöppel G: Pathology of nonendocrine pancreatic tumors; in Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA (eds): The Pancreas: Biology, Pathobiology and Disease, ed 2. New York, Raven Press, 1993, pp 871-897.
17. Löhr M, Trautmann B, Göttler M, Peters S, Zauner I, Maillet B, Klöppel G: Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. Br J Cancer 1994; 49:144-151.
18. Elsässer HP, Adler G, Kern HF: Time course and cellular source of pancreatic regeneration following acute pancreatitis in the rat. Pancreas 1986;1:421-429.
19. Elsässer HP, Adler G, Kern HP: Fibroblast structure and function during regeneration from hormone-induced acute pancreatitis in the rat. Pancreas 1989;4:169-178.
20. Elsässer HP, Haake T, Grimmig M, Adler G, Kern HF: Repetitive cerulein-induced pancreatitis and pancreatic fibrosis in the rat. Pancreas 1992;7:385-390.
21. Gress T, Müller-Pillasch F, Elsässer HP, Bachem M, Ferrara C, Weidenbach H, Lerch M, Adler G: Enhancement of transforming growth factor β1 expression in the rat pancreas during regeneration from cerulein-induced pancreatitis. Eur J Clin Invest 1994;24:679-685.
22. Menke A, Yamaguchi H, Gress TM, Adler G: Extracellular matrix is reduced by inhibition of transforming growth factor β1 in pancreatitis in the rat. Gastroenterology 1997;113:295-303.
23. Bockman DE, Merlino G: Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor-α. Gastroenterology 1992;103:1883-1892.
24. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC: Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia and carcinoma of the breast. Cell 1990;61:1121-1135.
25. Wagner M, Menke A, Bachem MG, Lührs H, Adler G, Schmid R: Kinetics of extracellular matrix formation and transdifferentiation in transgenic mice overexpressing transforming growth factor α in the exocrine pancreas. Gastroenterology 1997;112:A492.
26. Lee MS, Gu D, Feng L, Curriden S, Arnush M, Krahl T, Gurushanthaiah D, Wilson C, Loskutoff DL, Fox H, Sarvetnick N: Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-β1. Am J Pathol 1995;147:42-52.
27. Sanvito F, Nichols A, Herrera PL, Huarte J, Wohlwend A, Vassalli JD, Orci L: TGF-β1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-α triggers insulin-dependent diabetes. Biochem Biophys Res Commun 1995;217:1279-1286.
28. Böttinger EP, Jakubczak JL, Roberts ISD, Mumy M, Hemmati P, Bagnall K, Merlino G, Wakefiled LM: Expression of a dominant-negative mutant TGFβ type II receptor in transgenic mice revealy essential roles for TGFβ in regulation of growth and differentiation in the exocrine pancreas. EMBO J 1997;16:2621-2633.
29. Sparmann G, Merkrod J, Jäschke A, Nizze H, Jonas L, Löhr M, Liebe S, Emmerich J: Pancreatic fibrosis in experimental pancreatitis induced by dibutylin dichloride. Gastroenterology 1997;112:1664-1672.
30. 29a Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grünert A, Adler G: Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998; 115:421-432.
31. Gressner AM, Bachem MG: Molecular mechanisms of liver fibrogenesis: A homage to the role of activated fat-storing cells. Digestion 1995;56:335-346.
32. Saotome T, Inoue H, Fujimiya M, Fujiyama Y, Bamba T: Morphological and immunocytochemical identification of periacinar fibroblast-like cells derived from human pancreatic acini. Pancreas 1997;14:373-382.
33. Schneider E, Wolf CH, Weidenbach H, Adler G, Grünert A, Bachem MG: Untersuchungen zur Rolle polypeptidartiger Wachstumsfaktoren an mesenchymalen Zellen des Pancreas (abstract). J Lab Med 1996;20:686.
34. Bachem MG, Melchior R, Gressner AM: The role of thrombocytes in liver fibrogenesis: effects of platelet lysate and thrombocyte-derived growth factors on the mitogenic activity and glycosaminoglycan synthesis of cultured rat liver fat-storing cells. J Clin Chem Clin Biochem 1989;27:555-565.
35. Roberts CJ, Birkenmeier TM, McQuillan JJ, Akiyama SK, Yamada SS, Chen WT, Yamada KM, McDonald JA: Transforming growth factor β stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem 1988;263:4586-4592.
36. Yamanaka Y, Friess H, Büchler M, Beger HG, Gold LI, Korc M: Synthesis and expression of transforming growth factor β-1, β-2, and β-3 in the endocrine and exocrine pancreas. Diabetes 1993;42:746-756.
37. Sporn MB, Roberts AB: Transforming growth factor β: Recent progress and new challenges. J Cell Biol 1992;119:1017-:1021.
38. Van Laethem JL, Deviere J, Resibois A, Rickaert F, Vertongen P, Ohtani H, Cremer M, Miyazono K, Robberecht PL: Localization of transforming growth factor β1 and its latent binding protein in human chronic pancreatitis. Gastroenterology 1995;108:1873-1881.
39. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990;346: 371-374.
40. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoshlati E: Natural inhibitor of transforming growth factor beta protects against scaring in experimental kidney disease. Nature 1992;360:361-364.
41. Van Laethem JL, Robberecht P, Résibois A, Devière J: Transforming growth factor β promotes development of fibrosis after repeated courses of acute pancreatitis. Gastroenterology 1996;110:576-582.
42. Müller-Pillasch F, Gress TM, Yamaguchi H, Geng M, Adler G, Menke A: The influence of transforming growth factor β1 on the expression of genes coding for matrix metalloproteinases and tissue inhibitors of metalloproteinases during regeneration from cerulein-induced pancreatitis. Pancreas 1997;15:168-175.
43. Yamanaka Y, Friess H, Büchler M, Beger HG, Uchida E, Onda M, Kobrin MS, Korc M: Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993; 53:5289-5296.
44. Friess H, Yamanaka Y, Buchler M, Beger HG, Do DA, Kobrin MS, Korc M: Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol 1994; 144:117-128.
45. Ebert M, Yokoyama M, Friess H, Kobrin MS, Buchler MW, Korc M: Induction of platelet-derived growth factor A and B chains and overexpression of their receptors in human pancreatic cancer. Int J Cancer 1995;62:529-535.
46. Krane SM: Clinical importance of metalloproteinases and their inhibitors. Ann NY Acad Sci 1994;732:1-10.
47. Woessner JF: The family of matrix metalloproteinases. Ann NY Acad Sci 1994;732:11-21.
48. Okada Y, Gonji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T: Matrix metalloproteinase 9 (92 kDa gelatinase/ type IV collagenase) from HT1080 human fibrosarcoma cells: Purification and activation of the precursor and enzymic properties. J Biol Chem 1992;2267:21712-21719.
49. Murphy G, Cockett MT, Stephens NS, Gatter KC, Carmichael J: Stromelysin is an activator of procollagenase. Biochem J 1987;248:265-268.
50. Brown PD: Matrix metalloproteinase inhibitors in the treatment of cancer. Med Oncol 1997;14:1-10.
51. r 72,000 type IV collagenase in human colonie adenocarcinoma. Cancer Res 1991;51: 439-444.
52. Muller D, Wolf C, Abecassis J, Millon R, Engelmann A, Bonner G, Rouyer N, Rio MC, Eber M, Methlin G, Chambon P, Basset P: Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 1993;53:165-169.
53. Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A, Kossakowska AE: Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 1992;66:1188-1194.
54. Bramhall SR, Stamp GWH, Dunn J, Lemoine NR, Neoptolemos JP: Expression of collagenase (MMP2), stromelysin (MMP3) a tissue inhibitor of the metalloproteinase (TIMP1) in pancreatic and ampullary disease. Br J Cancer 1996;73:972-978.
55. Bramhall SR: The matrix metalloproteinases and their inhibitors in pancreatic cancer. Int J Pancreatol 1997;21:1-12.
56. Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hanse J, Eriksen J, Blasi F, Dano K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells or invasive foci in human colan adenocarcinomas. Am J Pathol 1991;138:1059-1067.
57. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD: Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 1993;90:5021-5025.
58. Paciucci R, Berrozpe G, Torà M, Navarro E, Garcia de Herreros A, Real FX: Isolation of tissue-type plasminogen activator, cathepsin H, and non-specific cross-reacting antigen from SK-PC-1 pancreas cancer cell lines using subtractive hybridization. FEBS Lett 1996;385: 72-76.
59. Cantero D, Friess H, Deflorin J, Zimmermann A, Brundler MA, Riesle E, Korc M, Büchler MW: Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic cancer. Br J Cancer 1997;75:388-395.
60. Müller-Pillasch F, Wallrapp C, Bartels K, Varga G, Friess F, Büchler M, Adler G, Gress TM: Cloning of a new Kunitz-type protease inhibitor overexpressed in pancreatic cancer. Biochim Biophys Acta 1998;1395:88-95.
61. Marlor CW, Delaria KA, Davis G, Muller DK, Greve JM, Tamburini PP: Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two kunitz domains. J Biol Chem 1997;272:12202-12208.
62. Delaria K, Muller DK, Marlor CW, Brown JE, Das RC, Roczniak SO, Tamburini PP: Characterization of placental bikunin, a novel human serine protease inhibitors. J Biol Chem 1997; 272:12209-12224.
63. McCachren SS: Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum 1991;34: 1085-1093.
64. Campo E, Merino MJ, Liotta L, Neumann R, Stetler-Stevenson W: Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue. Hum Pathol 1992;23: 1395-1401.
65. Friess H, Cantero D, Graber H, Tang WH, Guo X, Kashiwagi M, Zimmermann A, Gold L, Korc M, Büchler M: Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis. Gastroenterology 1997;113:904-913.
66. Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD: Control of lymphatic and hematogenous metastases of rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat. Cancer Res 1996;56:2815-2822.
67. Sledge GW, Qualali M, Goulet R, Bone EA, Fife R: Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 1995;87:1546-1550.
68. Anderson IC, Shipp MA, Docherty AJP, Teicher BA: Combination therapy including a gelatinase inhibtitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res 1996;56:715-720.
69. Stolow MA, Bauzon DD, Li J, Sedgwick T, Liang VC, Sang QA, Shi YB: Identification and characterization of a novel collagenase in Xenopus laevis: Possible roles during frog development. Mol Biol Cell 1996;7:1471-1483.
70. Cossins J, Dudgeon TJ, Catlin G, Gearing AJ, Clements JM: Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem Biophys Res Commun 1996;228: 494-498.
71. Pendas AM, Knauper V, Puente XS, Llano E, Mattei MG, Apte S, Murphy G, Lopez-Otin C: Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location and tissue distribution. J Biol Chem 1997; 272:4281-4286.
72. Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C: Molecular cloning of a novel membrane-type matrix metalloproteinase from human breast carcinoma. Cancer Res 1996;56: 944-949.